PMID: 16633199Apr 25, 2006Paper

ECT for treatment-resistant schizophrenia: a response from the far East to the UK. NICE report

The Journal of ECT
Worrawat Chanpattana, Chittaranjan Andrade

Abstract

There is controversy about the proper place of electroconvulsive therapy (ECT) in the management of the schizophrenic patient, and the important issues related to theory and practice remain to be resolved, especially in the context of medication-resistant schizophrenia. We briefly summarize existing research in the field. We next use a narrative method to describe in a single article the large body of research from Thailand that, during the past decade, has systematically studied issues related to the use of ECT in medication-resistant schizophrenia. We integrate the findings of the Thai efforts with the results of other research and consider the theoretical and practical importance of the reviewed work. The ECT treatment data validate a BRPS cutoff of 25 as a definition of recovery in patients with treatment-refractory schizophrenia, and a cutoff of 37 as a definition of subsequent relapse or suitability for entry into a treatment protocol. A 3-week post-ECT stabilization period identifies patients who maintain improvement and who can be legitimately considered to have sustained response to ECT. Clinical characteristics of such responders and symptoms responsive to ECT are described. Higher stimulus dose hastens response to EC...Continue Reading

Associated Clinical Trials

References

Feb 1, 1991·Archives of General Psychiatry·A RifkinM Wachspress
Aug 1, 1990·Archives of General Psychiatry·T Van PuttenJ Mintz
Aug 1, 1990·Archives of General Psychiatry·D F LevinsonP Silver
May 1, 1989·The British Journal of Psychiatry : the Journal of Mental Science·D Dodwell, D Goldberg
Jan 1, 1986·Annals of the New York Academy of Sciences·H A SackeimS Malitz
Aug 1, 1987·The British Journal of Psychiatry : the Journal of Mental Science·K R Abraham, P Kulhara
Aug 1, 1987·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·J LandmarkH Merskey
Feb 1, 1985·The British Journal of Psychiatry : the Journal of Mental Science·S BrandonS Wellstood-Eason
Jul 1, 1973·The British Journal of Psychiatry : the Journal of Mental Science·D R DoongajiS Ravindranath
Sep 1, 1980·The American Journal of Psychiatry·C Salzman
Jan 1, 1984·Schizophrenia Bulletin·D W HeinrichsW T Carpenter
Mar 1, 1983·The British Journal of Psychiatry : the Journal of Mental Science·K Koehler, H Sauer
Feb 1, 1994·Acta Psychiatrica Scandinavica·M AlbusS Burkes
Feb 15, 1996·Biological Psychiatry·S SzymanskiM Kronig
Jan 1, 1996·Schizophrenia Bulletin·M Fink, H A Sackeim
Jan 1, 1997·Schizophrenia Bulletin·R LewineR Shurett
Apr 16, 1998·The British Journal of Psychiatry : the Journal of Mental Science·B ShapiraB Lerer
Jul 11, 2000·Acta Psychiatrica Scandinavica. Supplementum·A Leung, P Chue
Mar 23, 2001·Acta Psychiatrica Scandinavica. Supplementum·A Riecher-Rössler, H Häfner
Dec 13, 2001·Psychiatry Research·W Chanpattana, M L Chakrabhand
Oct 24, 2002·The Journal of ECT·Chittaranjan Andrade, S Kurinji
Jul 1, 1962·The American Journal of Psychiatry·K WITTON
Dec 1, 1949·The American Journal of Psychiatry·E A ELLISON, D M HAMILTON
Nov 2, 2004·The British Journal of Psychiatry : the Journal of Mental Science·W Vaughn McCallPeter B Rosenquist
Nov 1, 1948·The American Journal of Psychiatry·D M HAMILTON, J H WALL

❮ Previous
Next ❯

Citations

May 28, 2008·European Archives of Psychiatry and Clinical Neuroscience·Brigitta BaranGábor Gazdag
Nov 30, 2011·Criminal Behaviour and Mental Health : CBMH·Diana KristensenMartin Balslev Jørgensen
May 19, 2016·The Journal of ECT·William M McDonaldW Vaughn McCall
Jan 13, 2018·The Journal of ECT·Martha FinneganDeclan M McLoughlin
Apr 14, 2011·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Iannis M ZervasCostantin R Soldatos
Dec 6, 2008·Journal of Psychiatric Practice·Anand K Pandurangi, Alican Dalkilic
Sep 1, 2015·Current Treatment Options in Psychiatry·Mehmet E Dokucu
Jul 10, 2019·Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists·Andrew TeodorczukGail Robinson
Dec 7, 2010·European Archives of Psychiatry and Clinical Neuroscience·Diana KristensenMartin Balslev Jørgensen
Oct 9, 2015·Journal of Child and Adolescent Psychopharmacology·Itziar FlamariqueInmaculada Baeza
Feb 24, 2015·Acta Neuropsychiatrica·Sandeep GroverNatasha Kate
Aug 9, 2018·Psychiatry Investigation·Jung Hyun KimIn Won Chung
Oct 13, 2009·Journal of Psychiatric Practice·Nancy A Payne, Joan Prudic
Dec 31, 2019·NeuroImage. Clinical·Julia A CamilleriThomas Nickl-Jockschat

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Benign Rolandic Epilepsy

Benign Rolandic epilepsy is a partial idiopathic epilepsy of childhood presenting with a nocturnal seizure and with a typical EEG showing centrotemporal spike and multifocal or generalized sharp slow waves. Here is the latest research.